Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-01-05 Sale(A) | 2024-02-16 4:32 pm | Athira Pharma Inc. | ATHA | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER | 2,412 | $2.91 | $7,019 | 80,256 (Direct) | View |
| 2023-01-05 Sale | 2024-01-08 4:36 pm | Athira Pharma Inc. | ATHA | CHURCH KEVIN Chief Scientific Officer | 2,412 | $2.91 | $7,019 | 80,256 (Direct) | View |
| 2022-06-23 Sale | 2022-06-24 7:25 pm | Athira Pharma Inc. | ATHA | CHURCH KEVIN Executive VP, Research | 2,614 | $2.69 | $7,032 | 57,695 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-14 Option Award | 2024-02-16 4:54 pm | N/A 2034-02-13 | Athira Pharma Inc. | ATHA | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER | 220,000 | $0 | 220,000 (Direct) | View |
| 2023-05-18 Option Award(A) | 2024-02-16 4:32 pm | N/A N/A | Athira Pharma Inc. | ATHA | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER | 809 | $2.41 | 80,256 (Direct) | View |
| 2024-01-04 Option Award(A) | 2024-02-16 4:32 pm | N/A N/A | Athira Pharma Inc. | ATHA | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER | 10,000 | $0 | 80,256 (Direct) | View |
| 2023-11-20 Option Award(A) | 2024-02-16 4:32 pm | N/A N/A | Athira Pharma Inc. | ATHA | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER | 3,397 | $1.34 | 80,256 (Direct) | View |
| 2023-05-18 Option Award | 2024-01-08 4:36 pm | N/A N/A | Athira Pharma Inc. | ATHA | CHURCH KEVIN Chief Scientific Officer | 809 | $2.41 | 80,256 (Direct) | View |
| 2023-01-04 Option Award | 2024-01-08 4:36 pm | N/A N/A | Athira Pharma Inc. | ATHA | CHURCH KEVIN Chief Scientific Officer | 10,000 | $0 | 80,256 (Direct) | View |
| 2023-11-20 Option Award | 2024-01-08 4:36 pm | N/A N/A | Athira Pharma Inc. | ATHA | CHURCH KEVIN Chief Scientific Officer | 3,397 | $1.34 | 80,256 (Direct) | View |
| 2023-03-24 Exercise | 2023-03-27 4:57 pm | N/A 2028-12-17 | Athira Pharma Inc. | ATHA | CHURCH KEVIN Chief Scientific Officer | 6,410 | $0 | 68,462 (Direct) | View |
| 2023-03-24 Exercise | 2023-03-27 4:57 pm | N/A N/A | Athira Pharma Inc. | ATHA | CHURCH KEVIN Chief Scientific Officer | 6,410 | $1.35 | 68,462 (Direct) | View |
| 2023-01-19 Option Award | 2023-01-23 5:26 pm | N/A 2033-01-18 | Athira Pharma Inc. | ATHA | CHURCH KEVIN Executive VP, Research | 150,000 | $0 | 212,052 (Direct) | View |
| 2022-11-18 Option Award | 2023-01-23 5:26 pm | N/A N/A | Athira Pharma Inc. | ATHA | CHURCH KEVIN Executive VP, Research | 657 | $2.74 | 212,052 (Direct) | View |
| 2022-10-28 Exercise | 2022-10-31 8:17 pm | N/A 2028-12-17 | Athira Pharma Inc. | ATHA | CHURCH KEVIN Executive VP, Research | 3,700 | $0 | 67,805 (Direct) | View |
| 2022-10-28 Exercise | 2022-10-31 8:17 pm | N/A N/A | Athira Pharma Inc. | ATHA | CHURCH KEVIN Executive VP, Research | 3,700 | $1.35 | 67,805 (Direct) | View |
| 2022-06-22 Option Award | 2022-06-24 7:25 pm | N/A N/A | Athira Pharma Inc. | ATHA | CHURCH KEVIN Executive VP, Research | 10,000 | $0 | 57,695 (Direct) | View |
| 2022-06-08 Exercise | 2022-06-10 5:53 pm | N/A 2028-12-17 | Athira Pharma Inc. | ATHA | CHURCH KEVIN Executive VP, Research | 2,500 | $0 | 60,419 (Direct) | View |
| 2022-06-08 Exercise | 2022-06-10 5:53 pm | N/A N/A | Athira Pharma Inc. | ATHA | CHURCH KEVIN Executive VP, Research | 2,500 | $1.35 | 60,419 (Direct) | View |
| 2022-05-18 Option Award | 2022-06-10 5:53 pm | N/A N/A | Athira Pharma Inc. | ATHA | CHURCH KEVIN Executive VP, Research | 243 | $7.06 | 60,419 (Direct) | View |
| 2022-02-18 Exercise | 2022-02-18 7:38 pm | N/A 2027-06-18 | Athira Pharma Inc. | ATHA | CHURCH KEVIN Executive VP, Research | 3,152 | $0 | 47,566 (Direct) | View |
| 2022-02-18 Exercise | 2022-02-18 7:38 pm | N/A N/A | Athira Pharma Inc. | ATHA | CHURCH KEVIN Executive VP, Research | 3,152 | $1.19 | 47,566 (Direct) | View |
| 2022-01-18 Option Award | 2022-01-20 5:24 pm | N/A 2032-01-17 | Athira Pharma Inc. | ATHA | CHURCH KEVIN Executive VP, Research | 100,000 | $0 | 144,414 (Direct) | View |
| 2021-11-18 Option Award | 2022-01-20 5:24 pm | N/A N/A | Athira Pharma Inc. | ATHA | CHURCH KEVIN Executive VP, Research | 96 | $12.51 | 144,414 (Direct) | View |
| 2021-06-08 Exercise(A) | 2021-06-10 6:41 pm | N/A 2026-08-30 | Athira Pharma Inc. | ATHA | CHURCH KEVIN Vice President of Discovery | 3,152 | $0 | 44,318 (Direct) | View |
| 2021-06-08 Exercise(A) | 2021-06-10 6:41 pm | N/A N/A | Athira Pharma Inc. | ATHA | CHURCH KEVIN Vice President of Discovery | 3,152 | $1.04 | 44,318 (Direct) | View |
| 2021-05-18 Option Award(A) | 2021-06-10 6:41 pm | N/A N/A | Athira Pharma Inc. | ATHA | CHURCH KEVIN Vice President of Discovery | 185 | $14.45 | 44,318 (Direct) | View |
| 2021-06-08 Exercise | 2021-06-09 5:39 pm | N/A 2026-08-30 | Athira Pharma Inc. | ATHA | CHURCH KEVIN Vice President of Discovery | 3,152 | $0 | 44,133 (Direct) | View |
| 2021-06-08 Exercise | 2021-06-09 5:39 pm | N/A N/A | Athira Pharma Inc. | ATHA | CHURCH KEVIN Vice President of Discovery | 3,152 | $1.04 | 44,133 (Direct) | View |
| 2021-02-18 Option Award | 2021-02-22 5:31 pm | N/A 2031-02-17 | Athira Pharma Inc. | ATHA | CHURCH KEVIN Vice President of Discovery | 20,000 | $0 | 20,000 (Direct) | View |
Ownership | 2020-09-17 8:31 pm | N/A N/A | Athira Pharma Inc. | ATHA | CHURCH KEVIN Vice President of Discovery | 0 | $0 | 129,880 (Direct) | View |